✨ Your Portfolio is fetched and updated from zerodha.
Small Pharmaceuticals

Wockhardt Ltd.

WOCKPHARMA

Market Cap
₹22,121 Cr.
P/E
1005.49

Wockhardt Ltd.

Key Ratios

Edit Ratio's
Market cap
Market cap
22,121 Cr
PE
PE
1,005
Prom Holding
Prom Holding
49.08 %
ROE (%)
ROE (%)
-
ROCE (%)
ROCE (%)
4.29
Div Yield (%)
Div Yield (%)
-
Sales
Sales
3,151 Cr
OPM (%)
OPM (%)
15.58 %
Debt to Equity
Debt to Equity
0.43
View more
Edit Ratio's

About

Wockhardt Limited is a global pharmaceutical and biotechnology organisation, providing afforda… Read more
Low
1087
52W Range
High
1869
  • Wockhardt
  • Pfizer
  • Astrazeneca Pharma I
  • TJI Pharma - Small Cap

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Company Timeline

Subscribe now for more updates

Custom financial statement

New
Edit rows

Forensics

8 Yes

Positive for this company

1 Neutral

Neutral for this company

7 No

Negative for this company

0 No Data

Insufficient data to analyse

Market Share

0.69 %
(as of Jul 22)
Historic
Anti - Diabetes - Market Share
0.05 %
(as of Jul 22)
Historic
Anti-Infectives - Market Share
0.01 %
(as of Aug 20)
Historic
Anti-Malarial - Market Share
0.05 %
(as of Nov 21)
Historic
Antineo Plastic - Market Share
4.31 %
(as of Nov 21)
Historic
Blood Related - Market Share
0 %
(as of Jul 22)
Historic
Cardiovascular - Market Share

Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Asset Break-Up

Operational Metrics

    locked
    Select a Metric
    • Domestic Sales Growth - YoY (%)
      Source
    • R&D as a % of Total Sales (%)
      Source

    Peer Comparison

    Brands

    Spasmo Proxyvon

    Corporate Actions

    Consolidated
    DATE
    DETAILS
    Show More
    Show Less
    Show More
    Show Less

    Suppliers

    • Shaily Engineering Plastics Ltd.
    • Borosil Renewables Ltd.
    • Responsive Industries Ltd.
    • Hindusthan National Glass & Industries Ltd.
    • Vivimed Labs Ltd.

    FAQs on Wockhardt Ltd. Business

    Wockhardt Limited is a prominent Indian pharmaceutical and biotechnology company that prioritizes accessibility to high-quality medicines. They are active in Pharmaceuticals, Biotechnology, and Super Speciality Hospitals.

    Wockhardt major competitors are Pfizer, Astrazeneca Pharma I, Natco Pharma, Eris Lifesciences, Gland Pharma, Jubilant Pharmova, Alembic Pharma.
    Market Cap of Wockhardt is ₹21,907 Crs.
    While the median market cap of its peers are ₹19,727 Crs.

    Wockhardt seems to be less financially stable compared to its competitors.
    Altman Z score of Wockhardt is 5.36 and is ranked 6 out of its 8 competitors.

    View FAQ's On Shareprice

    Company Filing

    Discussions & Analysis

    Wockhardt Ltd.
    Why Aditya Khemka Is Skeptical About Wockhardt's NCE Story - Accidental Investor Prince
    View The Discussion On ValuePickr - ValuePickr
    Pharmaceuticals
    GLP-1: The Drug Redefining Diabetes, Obesity, and Pharma’s Future - Perpetuity
    Understanding the CDMO Sector - Will It Be The Next Megatrend - SOIC
    Generic Opportunity for Indian Pharma Companies - Anish Moonka
    Nutraceuticals- Industry Overview - Value Educator
    Nutraceuticals - The Next Gem of Healthcare Sector - Shuchi Nahar
    Pharma Compliance In-Depth - Amit Rajan
    Deep Dive into Pharma Sector - Omkara Capital
    How The Pharma Industry Works - PPFAS
    Ideas Dashboard
    Results
    Timeline
    Watchlist
    Portfolio
    Alerts
    Stock Screener
    Market
    Raw Material